SCHEMBL6628490

SCHEMBL6628490

COc1ccc(-c2csc(-c3cnccc3C(C)C)n2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 3/20 0.58
CYP1A1 P04798 4/20 0.54
CYP1B1 Q16678 4/20 0.54
MAPT P10636 6/20 0.53
KDM4E B2RXH2 4/20 0.53
POLB P06746 2/20 0.53
ATM Q13315 1/20 0.53
SMN1; SMN2 Q16637 4/20 0.51
NPC1 O15118 3/20 0.51
RAB9A P51151 3/20 0.51
CYP1A2 P05177 2/20 0.50
CYP3A4 P08684 2/20 0.50
CDC25A P30304 1/20 0.50
CDC25B P30305 1/20 0.50
ALDH1A1 P00352 5/20 0.49
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
LMNA P02545 1/20 0.48
ALOX12 P18054 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6648507 0.88 KDM4E (0.53) CYP19A1KDM4ESMN1; SMN2NPC1RAB9A
SCHEMBL6649714 0.86 CYP19A1 (0.43) CYP19A1CYP1A1CYP1B1MAPTKDM4E
SCHEMBL6649082 0.85 KDM4E (0.61) CYP19A1MAPTKDM4EATMSMN1; SMN2
SCHEMBL6647162 0.85 KDM4E (0.61) CYP19A1MAPTKDM4EATMSMN1; SMN2
SCHEMBL6647407 0.84 KDM4E (0.59) CYP19A1KDM4ESMN1; SMN2NPC1RAB9A
SCHEMBL6647072 0.83 NPC1 (0.57) CYP19A1CYP1A1CYP1B1MAPTKDM4E
SCHEMBL6649092 0.81 GAA (0.50) CYP19A1CYP1A1CYP1B1KDM4ESMN1; SMN2
SCHEMBL6646446 0.81 KDM4E (0.55) CYP19A1KDM4ESMN1; SMN2NPC1RAB9A
SCHEMBL6629035 0.80 CYP19A1 (0.65) CYP19A1CYP1A1CYP1B1MAPTKDM4E
SCHEMBL4279334 0.80 KDM4E (0.75) CYP19A1CYP1A1CYP1B1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432706-A2 3-PYRIDYL OR 4-ISOQUINOLINYL THIAZOLES AS C17,20 LYASE INHIBITORS Bayer Pharmaceuticals Corporation (US) 2004-06-30 EP disclosed
WO-2003027085-A2 3-PYRIDYL OR 4-ISOQUINOLINYL THIAZOLES AS C17,20 LYASE INHIBITORS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed